IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 2222 
Small font sizeDefault font sizeIncrease font size
Read this article

 


    Article Cited by others

RESEARCH ARTICLE

Nature of action of sitagliptin, the dipeptidyl peptidase-IV inhibitor in diabetic animals

Davis Joseph A, Singh Shuchita, Sethi Sachin, Roy Subhasis, Mittra Shivani, Rayasam Geetavani, Bansal Vinay, Sattigeri Jitendra, Ray Abhijit

Year : 2010| Volume: 42| Issue : 4 | Page no: 229-233

   This article has been cited by
 
1 Comparison of vildagliptin twice daily vs. sitagliptin once daily using continuous glucose monitoring (CGM): Crossover pilot study (J-VICTORIA study)
Masaya Sakamoto,Rimei Nishimura,Taiga Irako,Daisuke Tsujino,Kiyotaka Ando,Kazunori Utsunomiya
Cardiovascular Diabetology. 2012; 11(1): 92
[Pubmed]  [Google Scholar] [DOI]
2 Compare clinical efficacy between vildagliptin 100 mg and sitagliptin 100 mg in inadequate patients with sitagliptin 50 mg
Kuribayashi, N.
Therapeutic Research. 2012; 33(5): 703-710
[Pubmed]  [Google Scholar]
3 Flavonoid rich fraction of Pilea microphylla (L.) attenuates metabolic abnormalities and improves pancreatic function in C57BL/KsJ-db/db mice
P. Bansal,P. Paul,G. Shankar,D. Munjal,P.G. Nayak,K.I. Priyadarsini,M.K. Unnikrishnan
Biomedicine & Preventive Nutrition. 2011; 1(4): 268
[Pubmed]  [Google Scholar] [DOI]
4 Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humans
Ahrén, B., Schweizer, A., Dejager, S., Villhauer, E.B., Dunning, B.E., Foley, J.E.
Diabetes, Obesity and Metabolism. 2011; 13(9): 775-783
[Pubmed]  [Google Scholar]
5 Clinical experience of a selective dipeptidyl peptidase IV inhibitor, vildagliptin
Tomioka, Y.
Therapeutic Research. 2011; 32(6): 841-849
[Pubmed]  [Google Scholar]
6 Target-mediated metabolism and target-mediated drug disposition of the DPPIV inhibitor AMG 222
Greene, R.J., Tu, H., Gibbs, J.P., Greg Slatter, J.
Xenobiotica. 2011; 41(11): 945-957
[Pubmed]  [Google Scholar]
7 Flavonoid rich fraction of Pilea microphylla (L.) attenuates metabolic abnormalities and improves pancreatic function in C57BL/KsJ-db/db mice
Bansal, P., Paul, P., Shankar, G., Munjal, D., Nayak, P.G., Priyadarsini, K.I., Unnikrishnan, M.K.
Biomedicine and Preventive Nutrition. 2011; 1(4): 268-272
[Pubmed]  [Google Scholar]
8 Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humans
B. Ahrén,A. Schweizer,S. Dejager,E. B. Villhauer,B. E. Dunning,J. E. Foley
Diabetes, Obesity and Metabolism. 2011; 13(9): 775
[Pubmed]  [Google Scholar] [DOI]
9 Target-mediated metabolism and target-mediated drug disposition of the DPPIV inhibitor AMG 222
Robert J. Greene,Hua Tu,John P. Gibbs,J. Greg Slatter
Xenobiotica. 2011; 41(11): 945
[Pubmed]  [Google Scholar] [DOI]

 

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow